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Cellular responses are determined by a number of signaling cues in the local microenvironment, such as growth factors and extracellular
matrix (ECM). In cultures of mammary epithelial cells (MECs), functional differentiation requires at least two types of signal, lactogenic
hormones (i.e., prolactin, insulin, and hydrocortisone) and the specialized ECM, basementmembrane (BM).Our previouswork has shown
that ECM affects insulin signaling in mammary cells. Cell adhesion to BM promotes insulin-stimulated tyrosine phosphorylation of insulin
receptor substrate-1 (IRS-1) and association of PI3Kwith IRS-1, whereas cells cultured on stromal ECMare inefﬁcient in transducing these
post-receptor events. Here we examine the mechanisms underlying ECM control of IRS phosphorylation. Compared to cells cultured on
BM, cells on plastic exhibit higher level of RhoA activity. The amount and the activity of Rho kinase (Rok) associated with IRS-1 are greater
in these cells, leading to serine phosphorylation of IRS-1. Expression of dominant negative RhoA and the application of Rok inhibitor
Y27632 in cells cultured on plastic augment tyrosine phosphorylation of IRS-1. Conversely, expression of constitutively active RhoA in
cells cultured on BM impedes insulin signaling. These data indicate that RhoA/Rok is involved in substratum-mediated regulation of insulin
signaling in MECs, and under the conditions where proper adhesion to BM is missing, such as after wounding and during mammary gland
involution, insulin-mediated cellular differentiation and survival would be defective.
Extracellular matrix (ECM) provides supportive, adhesive, and
barrier functions for tissues, and also triggers speciﬁc signaling
pathways and cytoskeleton reorganization. Various cellular
responses, including proliferation, differentiation, migration,
and survival are regulated by ECM. As these responses are also
controlled by growth factors, cross-talk between ECM- and
growth factor-activated signaling pathways has been proposed
and documented (Giancotti and Tarone, 2003; Streuli and
Akhtar, 2009). In this study, we explore possible mechanisms
linking ECM to the insulin signaling pathway, using mammary
epithelium as a model.
The breast is a glandular tissue composed of two types of
epithelial unit: the collecting ducts, and the alveoli. The latter
contain mammary epithelial cells (MECs) that adhere to a
specialized ECM, the basement membrane (BM) in vivo. This
interaction is necessary for the efﬁcient activation of speciﬁc
signaling pathways, for example those driven by prolactin and
insulin, but not EGF (Edwards et al., 1998; Lee and Streuli, 1999;
Wang et al., 2004). Recent ﬁndings have further revealed that
b1 integrin is required for proper prolactin signaling, and Rac
GTPase mediates this effect by decreasing the association of
SHP-2 with Jak2 (Naylor et al., 2005; Akhtar and Streuli, 2006).
Culture studies have shown that insulin is critical for MEC
differentiation and survival (Rosfjord and Dickson, 1999;
Hadsell and Abdel-Fattah, 2001; Marshman and Streuli, 2002).
Insulin initiates cascades of signaling via tyrosine
phosphorylation of the insulin receptor (IR). The active
receptor then recruits and phosphorylates Shc and the insulin
receptor substrate (IRS), which contain multiple tyrosine
residues and thus serve as docking proteins for downstream
signaling molecules (Taniguchi et al., 2006). Several lines of
evidence in a variety of cell systems have demonstrated that
ECM regulates insulin/IGF-I signaling at different levels, thereby
altering the intensity or duration of signaling.
First, ECM modulates the levels of insulin signaling
components. In IR-overexpressingCHO-T cells, internalization
of IR is decreased in cells adhered to galectin-8 compared to
those cultured on ﬁbronectin, collagen, or laminin
(Boura-Halfon et al., 2003). IRS-1 expression is also modulated
by adhesion; in DA2 ﬁbroblasts this occurs at the
transcriptional level, primarily through FAK (Lebrun et al.,
2000). Second, integrins can regulate the phosphorylation of
insulin/IGF-I signaling components by interacting with them. In
3T3 and Rat1 ﬁbroblasts, adhesion promotes the association of
avb3 integrin with IR, while in CHO or PC3 cells
overexpressing b1 integrin, b1 integrin interacts with IGF-I
receptor (IGF-IR) and IRS-1 in an IGF-I-dependent and
independent manner, respectively (Schneller et al., 1997; Goel
et al., 2004). In addition to avb3 and b1 integrin, a6 integrin
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associates with IGF-IR in embryonic lens cells in vivo (Walker
et al., 2002). Interestingly, in T47D cells or MDA-MB-435 cells
overexpressing b4 integrin, engagement of a6b4 integrin itself
induces tyrosine phosphorylation of IRS-1 (Shaw, 2001). Third,
tyrosine kinases downstream of integrin may be involved in
insulin signaling, since FAK directly associates with IRS-1 in
293 cells overexpressing FAK, and transient expression of FAK
together with Src restores insulin-induced tyrosine
phosphorylation of IR and IRS-1 in suspended 3T3 cells that
overexpress IR (Lebrun et al., 1998; El Annabi et al., 2001).
Finally, ECM can prevent the dephosphorylation of insulin/IGF-I
signaling components. In smooth muscle cells, avb3 integrin
prolongs tyrosine phosphorylation of IGF-IR through a control
on the rate of SHP-2 recruitment to the activated receptor
(Maile and Clemmons, 2002). In pancreatic adenocarcinoma
cell lines, MIA PaCa-2 and PANC-1, cell adhesion to ﬁbronectin
transactivates IGF-IR by preventing SHP-2 from
dephosphorylating IGF-IR (Edderkaoui et al., 2007).
Many of these studies are restricted to overexpression
analysis in a variety of cell and cancer lines, and no work has
approached the mechanism of this cross-talk in normal
epithelia. We have demonstrated that in primary cultures of
normal MECs, insulin signaling propagates more effectively in
cells plated on BM than in those on a stromal ECM represented
by native collagen I or on tissue culture plastic (where cells
adhere to ﬁbronectin and vitronectin deposited from serum)
(Farrelly et al., 1999; Lee and Streuli, 1999). Greater extents of
IRS-1 tyrosine phosphorylation and IRS-1/PI3K association take
place in cells cultured on BM; however, levels of tyrosine
phosphorylation of IR are comparable in cells on both substrata.
We have therefore argued that ECMmodulates insulin signaling
downstream of the receptor at the level of IRS-1 tyrosine
phosphorylation.
In this study we have explored the underlying mechanisms of
how ECM regulates insulin signaling, with an emphasis on the
RhoA/Rho kinase (Rok) pathway and protein tyrosine
phosphatases (PTPs), using primary cultures of MECs isolated
directly from mammary gland.
Materials and Methods
Reagents
Murine EGF, bovine insulin, and hydrocortisone were purchased
from Sigma (St. Louis, MO). Antibody to Rok was obtained from
Becton Dickinson (Bedford, MA). Antibody to phospho-IRS-1
(Ser636/639) was from Cell Signaling (Beverly, MA). Antibodies to
IR, RhoA, SHP-2, hemagglutinin (HA) and myosin phosphatase
target subunit 1 (MYPT1) were from Santa Cruz Biotechnology
(Santa Cruz, CA). Rho activation assay kit, recombinant MYPT1
(654–880) and antibodies to phosphotyrosine (clone 4G10), IRS-1
and phospho-MYPT1 were from Upstate Biotechnology (Lake
Placid, NY). Y27632 was obtained from Calbiochem (San Diego,
CA).
Substrata and cell culture
Reconstituted BM matrix, Matrigel, was purchased from Becton
Dickinson and coated onto dishes at 7 mg/ml. All experiments
were performed with ﬁrst or second passage MECs derived from
mid-pregnant ICR mice. Primary epithelial cultures were prepared
from isolated mammary alveoli and cultured in nutrient mixture
F-12 (Sigma) containing 10% fetal calf serum (Hyclone, Logan, UT),
1 mg/ml fetuin (Sigma), 5 ng/ml EGF and 1 mg/ml hydrocortisone.
The cells were plated onto Matrigel, serum-treated tissue culture
plastic dishes (where the cells adhere to ﬁbronectin and
virtonectin), or 2 mg/ml collagen I renatured from HAc-dissolved
rat tail collagen ﬁbrils. After 72 h, cells were serum-starved 6–8 h in
Dulbecco’s modiﬁed Eagle’s medium/nutrient mixture F-12
(Invitrogen,Grand Island,NY) containing hydrocortisone, and then
subjected to various treatments.
Adenovirus infection
Recombinant adenovirus carrying HA-tagged dominant negative
RhoA (N19RhoA) and constitutively active RhoA (L63RhoA) were
generated as previously described (Ming et al., 2002). For cells
cultured on plastic, recombinant adenovirus was added to cells
directly; whereas for those cultured on BM, cells were trypsinized,
infected in suspension at 378C for 1 h, and then plated onto
Matrigel-coated dishes (Watkin and Streuli, 2002). After incubated
with adenovirus for 18–24 h, cells were serum-starved for 6–8 h,
and stimulated with insulin (100 nM) for 15 min.
Immunoprecipitation and Western blot analysis
Untreated or growth factor-treated cells were lysed in lysis buffer
containing 50 mM Tris (pH 7.4), 150 mM NaCl, 2 mM EDTA,
1mMNa3VO4, 10mMNaF, 10mg/ml aprotinin, 10mg/ml leupeptin,
1 mM phenylmethylsulfonyl ﬂuoride, and 1% Triton X-100.
Normalization of protein was conﬁrmed by SDS–PAGE, followed
by Coomassie Blue staining. Cell lysates containing equal
amounts of protein were incubated with 1–2 mg of antibody and
20–50 ml of protein A-Sepharose beads (Zymed Laboratories,
Inc., South San Francisco, CA) overnight at 48C.
Immunoprecipitates or whole cell lysates were subjected to
SDS–PAGE, transferred to PVDF membrane (NEN), and
probed with antibodies to anti-phosphotyrosine
(4G10; 1 mg/ml), IR (1 mg/ml), IRS-1 (1 mg/ml), phospho-IRS-1
(Ser636/639) (1:1,000), RhoA (2 mg/ml), HA (1 mg/ml), Rok
(1mg/ml), phospho-MYPT1 (2mg/ml),MYPT1 (1mg/ml), and SHP-2
(1mg/ml). Proteins were visualized using an ECL kit (Cell Signaling).
In each of the studies presented, the results shown are typical of
three independent experiments.
Rho activity assay
Measurement of RhoA activation was performed according to
manufacturer’s instructions (Upstate Biotechnology). Brieﬂy,
cleared cell lysates were incubated for 1 h at 48C with
GST-Rhotekin Rho-binding domain bound to glutathione-agarose
beads to precipitateGTP-boundRho. Total lysates and precipitates
were analyzed by Western blotting using antibody to RhoA.
Rok activity assay
IRS-1 associated Rok activity was measured according to
manufacturer’s instructions (Upstate Biotechnology) with minor
modiﬁcations. Brieﬂy, IRS-1 immunoprecipitates were incubated
with 500 ng recombinantMYPT1 (654–880) and 200mMATP (Cell
Signaling) in kinase buffer (Cell Signaling) for 30 min at 308C. The
reaction was stopped by adding Laemmli sample buffer, and then
boiled for 5 min. Phosphorylation of MYPT1 was assessed by
immunoblotting using antibody to phospho-MYPT1.
In-gel PTP assay
Experimental procedures followed the protocol reported by
Burridge and Nelson (1995). Brieﬂy, 1 mg of poly(glutamate/
tyrosine) (Sigma) was incubated with 500–1,000 U of v-abl kinase
(Calbiochem) and 500 mCi of [g-32P]ATP in 0.5 ml kinase buffer
(30 mM MgCl2, 1 mM MnCl2, 1 mM Na3VO4, 0.2–1 mM ATP,
10 mM dithiothreitol, 0.05% Triton X-100, 50 mM imidazole,
pH 7.2) at room temperature for 18 h, and the reaction was
terminated by addition of an equal volume of 20% trichloracetic
acid. After 30 min on ice, the precipitated poly(glu/tyr) were
sedimentated at 12,000g for 10min at 48C.The pelletwas dissolved
in 2 M Tris-base, passed over a G50 Sephadex column
equilibrated in 50 mM imidazole, pH 7.2, and collected in 0.5 ml
fractions. 32P-labeled substrate was added into the regular
polyacrylamide gel mix prior to polymerization at 105 cpm/ml.
Sampleswere separated by SDS–PAGE. Following electrophoresis,
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gels were ﬁrst incubated in 50 mM Tris–HCl, pH 8.0, containing
20% isopropanol overnight to remove the SDS. Gels were
then washed twice in 50 mM Tris–HCl, pH 8.0, containing
0.3% b-mercaptoethanol, and denatured by incubating with the
same buffer containing 6 M guanidine hydrochloride and 1 mM
EDTA for 90 min. The gels were then incubated three times in
renaturation buffer (1 mM EDTA, 50 mM Tris–HCl, pH 8.0,
0.3% b-mercaptoethanol, and 0.04% Tween-40). The gels were
ﬁnally incubated overnight in renaturation buffer containing 4 mM
dithiothreitol. Following this incubation, the gels were stained with
Coomassie brilliant blue, destained, and dried for autoradiography.
The clear bands in a black background represent where PTPs
localize.
Results
MECs cultured on plastic exhibit higher level of
RhoA activity
Our previous work demonstrated that the nature of the
substratum that MECs adhere to affects insulin signaling
downstream of its receptor, at the level of IRS-1 tyrosine
phosphorylation (Farrelly et al., 1999; Lee and Streuli, 1999).
The aim of this study was to further identify the mechanism for
differential IRS activation in MECs grown on two substrata,
tissue culture plastic where cells form monolayers and are
poorly responsive to insulin, and BM where cells form
three-dimensional acini and show robust insulin-activated
signaling.
One approach to delineate the mechanism is to ﬁnd out the
differences in signaling pathways triggered by cell adhesion to
plastic and BM, and then evaluates the involvement of these
pathways in modulating insulin signaling. Among the pathways
known to be activated by cell adhesion, we were particularly
interested in Rho since its downstream effector Rok has been
shown to regulate insulin signaling (Farah et al., 1998; Begum
et al., 2002; Furukawa et al., 2005; Kanda et al., 2006; Lim et al.,
2007).We found thatMECs cultured on plastic displayed higher
RhoA activity than those cultured on BM (Fig. 1). In addition,
when cells were cultured inmonolayers on collagen I, therewas
a similar level of RhoA activity as in cells cultures on plastic (data
not shown).
This result shows that activation of RhoA is differentially
regulated by cell adhesion to different substrata.
RhoA activity is detrimental for insulin signaling in MECs
We then went on to examine whether RhoA accounted for the
defectiveness of insulin signaling in MECs cultured on plastic.
Lowering RhoA activity by expressing dominant negative RhoA
(N19RhoA) augmented insulin-induced IRS-1 tyrosine
phosphorylation by up to 1.8-fold (Fig. 2B, lane 4 vs. lane 2, and
Fig. 2C). In contrast, expression of constitutively active RhoA
(L63RhoA) inhibited IRS-1 tyrosine phosphorylation by 52% in
MECs cultured onBM (Fig. 2E, lane 4 vs. lane 2, and Fig. 2F). Both
treatments hadmarginal effects on IR tyrosine phosphorylation,
but these were not statistically signiﬁcant (Fig. 2A,C,D,F).
Collectively, these data suggest that culture on plastic, a
substratum that is not suitable for optimal insulin signaling,
activates RhoA, which in turn blocks insulin signaling in MECs.
Rok binds and phosphorylates IRS-1 in cells
cultured on plastic
A number of downstream effectors are activated by RhoA,
including Rok. Rok is a serine/threonine kinase and is involved in
several cellular responses, such as stress ﬁber formation,
actinomyosin contraction, cell–substratum adhesion, cell–cell
interaction, migration, cytokinesis, apoptosis, and gene
expression (Riento and Ridley, 2003). One notable function of
Rok is to regulate insulin/IGF-I signaling. It has been shown to
bind and phosphorylate IRS-1, thereby suppressing tyrosine
phosphorylation of IRS-1 (Farah et al., 1998; Begum et al., 2002;
Lim et al., 2007). Based on these ﬁndings, we examined the
extent of association of Rok with IRS-1 in MECs cultured on
different substrata. A higher amount of Rok was
co-immunoprecipitated with IRS-1 in cells cultured on plastic
(Fig. 3A), coinciding with greater Rok activity associated with
IRS-1 in these cells (Fig. 3B). The IRS-1-associatedRok activity in
cells cultured on plastic was 3.6-fold more than that in cells
cultured on BM (Fig. 3C).
Since Rok bound to IRS-1 might directly phosphorylate
IRS-1, we then measured IRS-1 phosphorylation at serine
residues 307, 612, and 636/639 by immunoblotting.
Serine phosphorylation of IRS-1 at residues 307 and 612 was
not detected inMECs regardless the substratum. However, the
level of serine phosphorylation at residues 636/639 was higher
in cells cultured on plastic (Fig. 4A), and this was diminished by
the treatment of Y27632, a Rok inhibitor (Fig. 4B).
Our data thus suggest that higher RhoA activity in MECs
cultured on plastic leads to greater association of Rok with
IRS-1, resulting in phosphorylation at serine residues.
Inhibition of Rok activity by Y27632 increases tyrosine
phosphorylation of IRS-1 in MECs cultured on plastic
Serine phosphorylation of IRS-1 exerts a negative impact on
IRS-1 tyrosine phosphorylation. Various serine/threonine
kinases phosphorylate IRS-1, including PKC, Erk, JNK, IKKb,
and Rok, as well as downstream effectors in the
insulin-stimulated PI3K pathway, comprising GSK-3, mTOR,
and p70S6K (reviewed by Zick, 2001; Johnston et al., 2003;
Taniguchi et al., 2006). Given that greater extent of Rok binds
and phosphorylates IRS-1 in MECs cultured on plastic (Figs. 3
and 4), we examined whether inhibition of Rok activity by
Y27632 could ameliorate insulin-induced tyrosine
phosphorylation of IRS-1. Indeed, inclusion of Y27632
enhanced level of tyrosine phosphorylation of IRS-1 in response
to insulin by twofold in these cells (Fig. 5B, lane 3 vs. lane 1), but
did not affect tyrosine phosphorylation of IR (Fig. 5A). For cells
cultured on BM, no signiﬁcant effect of Y27632 on insulin
signaling was observed (Fig. 5C,D), presumably because it was
already maximal.
Taken together, our results suggest that the inefﬁciency of
insulin signaling in MECs cultured on plastic is due to, at least in
part, over-activation of RhoA/Rok pathway, leading to IRS-1
serine phosphorylation and thus disruption of insulin signaling
propagation downstream of IR. In contrast, MECs cultured on
BM exhibit low level of RhoA, thereby acquiring full capacity of
insulin signaling.
Fig. 1. MECs cultured on plastic exhibit higher RhoA activity. MECs
were cultured on plastic (PL) or BM. Cell lysates were incubated with
GST-Rhotekin bound to glutathione-agarose beads to precipitate
GTP-boundRho. Total lysates andprecipitateswere then analyzedby
immunoblotting using antibody to RhoA.
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PTPs association with IR and IRS-1
Our previous work revealed that the PTP inhibitor, vanadate,
elevates the tyrosine phosphorylation of IRS-1 in MECs
cultured on collagen I or plastic, although the mechanism
was not determined (Lee and Streuli, 1999). Never-the-less,
these data suggest that an additional mechanism for the
ECM-mediated modulation of IRS-1 tyrosine phosphorylation
Fig. 2. ExpressionofdominantnegativeRhoA improves insulin signaling inMECsculturedonplastic,whereasexpressionof constitutivelyactive
RhoA inhibits insulin signaling inMECsculturedonBM.MECsculturedonplasticwere infectedwithadenovirus carryingdominantnegativeRhoA
(Ad-N19RhoA) or LacZ in situ (A,B). MECs cultured on BM were trypsinized, infected with adenovirus carrying constitutively active RhoA
(Ad-L63RhoA) or LacZ, and replated onBM (D,E). After 24 h, cells were serum-starved for 8 h and stimulatedwith 100 nM insulin for 15min. Cell
lysates were immunoprecipitated (IP) with antibody to IR (A,D) or IRS-1 (B,E), followed by immunoblotting with anti-phosphotyrosine
antibody (PY). Blots were stripped and reprobed with the appropriate precipitating antibodies. Expression of HA was monitored by
immunoblotting. C,F: Quantiﬁcation of the effect of N19RhoA (C) and L63RhoA (F) on insulin signaling. Immunoblots from three independent
experimentswere analyzed by densitometry, and data are expressed as fold stimulationwith respect tomock-infected cells. MP<0.05; MMP<0.01.
Fig. 3. Theamount andactivityofRokassociatedwith IRS-1 arehigher inMECsculturedonplastic.A:MECsculturedonplastic (PL)orBMwere
incubated in the absence or presence of 100 nM insulin for 15min. Cell lysates were immunoprecipitated (IP) with antibody to IRS-1, followed by
immunoblotting with anti-Rok antibody. The blot was then stripped and reprobed with antibody to IRS-1. B,C: Cell lysates were
immunoprecipitated with antibody to IRS-1 followed by Rok activity assay using recombinant MYPT1 as a substrate. The extent of MYPT1
phosphorylationwasmonitoredby immunoblottingwithanti-phospho-MYPT1antibody.Theblotwasthenstrippedandrepobedwithantibodyto
MYPT1. IRS-1 level in immunoprecipitates was also monitored by immunoblotting. C: Immunoblots of p-MYPT1 and IRS-1 were quantiﬁed by
densitometricanalysis.RelativeRokactivityassociatedwithIRS-1wascalculatedbydividingvalueof intensityofp-MYPT1bythatof IRS-1.Dataare
expressed as meanWSE from three separate experiments.
ht
tp
://
do
c.
re
ro
.c
h
4
may involve a PTP. To search for possible PTPs associated with
IRS-1 or the receptor complex, an in-gel PTP assay was
performed (Burridge and Nelson, 1995). Phosphorylated
poly(glutamate–tyrosine) was incorporated into acrylamide
gels, and samples were separated by SDS–PAGE. Following
electrophoresis, gels were subjected to denaturation and then
renaturation, and PTP activity was detected by
autoradiography. The clear bands in a black background
represent where PTPs localize. This method does not resolve
membrane-associated PTPs, but is useful for possible
identiﬁcation of soluble PTPs.
The overall proﬁle of PTPs from total cell lysates using the
in-gel PTP assay was initially obtained. Similar patterns but
different intensities of PTP were observed in MECs cultured on
the two different substrata (Fig. 6). PTPs with a molecular
weight of 130 and 65 kDa were predominant in cells
cultured on plastic (asterisk), whereas those at the size of
35 and40 kDawere detectedmainly in cells cultured on BM
(circle). Insulin stimulation did not alter the PTP proﬁle. This
result suggests that cell–ECM interaction may affect PTP
expression or activity in MECs.
We then examined the possibility that adhesion to different
substrata inﬂuences the association of PTPs with IRS-1 or IR.
Thus, IR and IRS-1 immunoprecipitates were subjected to the
in-gel PTP assay. Multiple PTPs coprecipitated with IR, but their
levels did not change in response to insulin or the substratum
(Fig. 7A). Notably, the migration proﬁle of these PTPs on SDS
gels is distinct to that of the overall PTP proﬁle (compare Figs. 6
and 7), indicating that they represent a set of PTPs that associate
speciﬁcally with IR. By contrast, insulin stimulated the
association of a70 kDaPTPwith IRS-1 (Fig. 7B). This occurred
Fig. 4. MECs culturedonplastic exhibit higher extent of IRS-1 serine
phosphorylation, and this can be inhibited by Y27632. A: Total cell
lysates obtained from MECs cultured on plastic (PL) and BM were
analyzed by immunoblotting with antibodies to phospho-IRS-1
(Ser636/639) and IRS-1. B: MECs cultured on PL were pretreated
without or with 10 or 25 mM Y27632 for 1 h, and cell lysates were
analyzed by immunoblotting with antibodies to phospho-IRS-1
(Ser636/639) and IRS-1.
Fig. 5. Y27632enhancesinsulinsignaling inMECsculturedonplastic.MECsculturedonplastic(PL)(A,B)orBM(C,D)werepretreatedwithoutor
with 10 or 25 mMY27632 for 1 h, and then incubated with 100 nM insulin for 15min. Cell lysates were immunoprecipitated (IP) with antibody to
IR (A,C) or IRS-1 (B,D), followed by immunoblotting with anti-phosphotyrosine antibody (PY). Blots were stripped and reprobed with the
appropriate precipitating antibodies.
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in cells on both substrata, but the presence of this band was
greater in cells cultured on BM (Fig. 7B, lane 2 vs. lane 4). This
PTP may correspond to SHP-2 since it migrates at
approximately the same size as the major band from SHP-2
immunoprecipitates (data not shown). To conﬁrm this,
immunoprecipitation of IRS-1 followed by immunoblottingwith
SHP-2 antibody was carried out. In agreement with Figure 7B, a
higher level of SHP-2 was associated with IRS-1 upon insulin
stimulation in cells cultured on BM (Fig. 7C).
The recruitment of SHP-2 to IRS-1 requires IRS-1 to be
tyrosine phosphorylated ﬁrst. We therefore hypothesized that
more SHP-2 binds to IRS-1 in MECs cultured on BM because of
its higher level of tyrosine phosphorylation.
To test this possibility, we determined the effect of
RhoA/Rok on insulin-induced recruitment of SHP-2 to IRS-1.
Overexpression of constitutively active RhoA inMECs cultured
on BM resulted in a decline in both IRS-1 tyrosine
phosphorylation and the extent of IRS-1/SHP-2 association
(Fig. 8A). The converse experiment of including Y27632 in
MECs cultured on plastic caused elevation of both tyrosine
phosphorylation and SHP-2 binding (Fig. 8B). These results
suggest that the recruitment of SHP-2 to IRS-1 is not an
upstream event controlling IRS-1 tyrosine phosphorylation, but
rather it is secondary to IRS-1 tyrosine phosphorylation.
Thus, Rho/Rok exerts a negative effect on insulin signaling via
a mechanism that does not involve SHP-2. Here we infer that
SHP-2 might have a positive role in insulin signaling as reported
by others (Maegawa et al., 1999).
Discussion
In MECs, insulin potentiates prolactin-induced milk protein
gene expression and promotes cell survival (Farrelly et al., 1999;
Lee and Streuli, 1999). These effects are apparent in cells
cultured on BM, a substratum that is permissive for insulin
signaling, but not in cells cultured on plastic dishes. We
previously discovered that ECM regulates insulin signaling at
the level of IRS-1 tyrosine phosphorylation, and here we
explore the mechanism of IRS regulation (Lee and Streuli,
1999). We demonstrate that cell adhesion to plastic activates
RhoA and the downstream effector Rok, which then binds and
phosphorylates IRS-1 on serine residues, leading to inhibition of
IRS-1 tyrosine phosphorylation.
This differential activation of insulin signaling according to
ECM contact is conceptually important because it explains in
part why MECs survive and differentiate on BM, but are unable
to do so when cultured on stromal ECM. Moreover, it has
Fig. 6. The overall PTP expression proﬁle is altered according to
the substratum that MECs are cultured on. MECs cultured on plastic
(PL) or BM were incubated in the absence and presence of 100 nM
insulin for 15 min. Total cell lysates were subjected to in-gel PTP
assay. PTPs predominantly expressed inMECs culturedonplastic and
BM are denoted by * and -, respectively.
Fig. 7. PTP association with IR and IRS-1. MECs cultured on plastic (PL) or BMwere incubated in the absence or presence of 100 nM insulin for
15 min. A,B: Total cell lysates were immunoprecipitated (IP) with antibody to IR (A) or IRS-1 (B), followed by in-gel PTP assay. C: Total
cell lysateswereimmunoprecipitatedwithanti-IRS-1antibodyfollowedbyimmunoblottingwithantibodytoSHP-2.Theblotwasthenstrippedand
reprobed with antibody to IRS-1.
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developmental importance because if MECs, which normally
contact BM in vivo, migrate into another ECM environment
such as the subtending stroma, they undergo apoptosis. This is a
key mechanism to maintain epithelial positioning within mature
tissues and provides a strong selection to prevent inappropriate
migration in malignancy (Streuli, 2006).
RhoA is activated in culls cultured on plastic
In our study, all experiments were performed in cells cultured
on plastic or BM for at least 3 days. A striking difference
between these cells is theirmorphology.MECson plastic form a
monolayer, whereas those on BM adopt an alveolar structure.
Thus, it is conceivable that biochemical signals elicited by cell
adhesion to these substrata are different. Indeed, our results
indicate that RhoA is predominantly activated in cells cultured
on plastic. Since MECs on BM still maintain the differentiated
phenotype and survive but cells cultured on plastic do not, our
result is consistent with previous observations that
laminin-induced cell differentiation is accompanied by
downregulation of RhoA activity (Gout et al., 2001; Beqaj et al.,
2002).
Another possibility for the differential activation of RhoA is the
rigidity of the substratum. T47D breast epithelial cells cultured on
plastic or 2D collagen exhibit higher level of RhoA than those on a
3D ﬂoating collagen gel (Wozniak et al., 2003). BM, like the 3D
ﬂoating collagen gel, is pliable compared to the rigid surface of
plastic dishes, and it has been proposed that cells exposed to
malleable conditions do not need much RhoA activity to exert
internal contractility because theopposing tension generated from
cell adhesion is weaker (Olson, 2004). In addition to the
composition and ﬂexibility of the substratum, cell–cell interactions
also inﬂuence RhoA activity, and vice versa. Cadherin engagement
inhibits RhoA via tyrosine phosphorylation of p190RhoGAP
(Noren et al., 2003). Conversely, constitutive activation of RhoA
disrupts tight junction and adherens junction in rat mammary
epithelial tumor cells (Rubenstein et al., 2003). Therefore, cells
cultured on BM have lower degree of RhoA activity since MECs
require proper cell–cell junctions to achieve alveolar morphology
and differentiation.
Thus a unifying explanation for the inefﬁcient insulin signaling
in MECs cultured in the conventional way (i.e., on tissue culture
plastic) is that increased tension generated by adhesion to a
rigid surface, leads to RhoA activation and the consequent
Rok-induced inhibition of insulin signaling. Although such
conditions do promote stress ﬁber formation and motility,
which are important mediators of the wound-healing response,
the same environment is not conducive for cellular
differentiation and not ideal for epithelial cell survival.
Rok is activated in cells cultured on plastic and causes
serine phosphorylation of IRS-1
Serine phosphorylation of IRS plays an important role in the
control of insulin signaling. IRS phosphorylation mediated by
PKB and 50-AMP-activated protein kinase (AMPK) is beneﬁcial
to insulin signaling, whereas the effect of PKC, Erk, JNK, IKKb,
GSK-3, mTOR, p70S6K, and Rok is detrimental (reviewed by
Zick, 2001; Johnston et al., 2003; Taniguchi et al., 2006).
Regarding the latter, several mechanisms have been elucidated.
Serine phosphorylation of IRS can cause dissociation of IRS
from IR, suppression of IRS-1 tyrosine phosphorylation,
alteration of the subcellular location of IRS-1, augmentation of
IRS degradation and inhibition of IR tyrosine kinase activity. All
of these events lead to diminishment of insulin signaling. Here
we found that MECs cultured on plastic exhibited higher extent
of IRS-1 serine phosphorylation (Fig. 4A). This might hinder the
association of IRS-1 with IR since we have observed that IR and
IGF-IR form hybrid receptors in MECs, but the recruitment of
IRS-1 to the receptor complex in response to insulin is impaired
in cells cultured on plastic (data not shown). Conceivably,
downregulation of IRS-1 tyrosine phosphorylation would thus
take place (Lee and Streuli, 1999).
Among the serine/threonine kinases involved in IRS-1 serine
phosphorylation, Rok, a downstream effector of Rho (Riento
and Ridley, 2003), is emerging as an important regulator of
insulin/IGF-I signaling. A Xenopus homolog of Rok binds to the
PTB domain of IRS-1, and microinjection of the mRNA
corresponding to the C-terminus of Rok inhibits
insulin-induced oocyte maturation (Farah et al., 1998). In
vascular smooth muscle cells, Rok activation in response to
thrombin results in an increase in its association with IRS-1,
parallel with the enhancement of IRS-1 serine phosphorylation
and inhibition of insulin signaling (Begum et al., 2002). The role
Fig. 8. Insulin-induced recruitment of SHP-2 to IRS-1 is repressed upon overexpressing constitutively active RhoA, but is augmented by
Y27632 treatment. A: MECs cultured on BM were trypsinized, mock-infected or infected with adenovirus carrying constitutively active RhoA
(Ad-L63RhoA), andreplatedonBM.After24h, cellswereserum-starved for8handstimulatedwith100nMinsulin for15min.B:MECsculturedon
plastic (PL) were serum-starved for 8 h, pretreated without or with 15 mM Y27632 for 1 h, and then incubated with 100 nM insulin for 15 min.
Total cell lysateswere immunoprecipitated (IP)withantibodyto IRS-1, followedby immunoblottingwithanti-phosphotyrosineantibody (PY)and
SHP-2. Blots were then stripped and reprobed with antibody to IRS-1.
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of Rok in insulin resistance has also been documented in several
reports. Compared to the lean rats, RhoA/Rok activity and level
of IRS-1 seine phosphorylation are elevated in obese rats,
coinciding with the reduction of insulin-induced signaling and
responses (Kanda et al., 2006). Similar effects of Rok were
observed in vascular endothelial cells because C-reactive
protein, a molecule related to insulin resistance, activates
RhoA/Rok/JNK via spleen tyrosine kinase (Syk), rendering
serine phosphorylation of IRS-1 and suppression of insulin
responses (Xu et al., 2007). During muscle differentiation and
adipogenesis mediated by insulin and IGF-I, a decline of
RhoA/Rok activity occurs and inhibition of Rok facilitates
differentiation. Likewise, upregulation of IRS-1 serine
phosphorylation and downregulation of insulin/IGF-1 signaling
are associated with higher Rok activity (Lim et al., 2007;
Noguchi et al., 2007).
In concordance with these studies, we demonstrate here
that RhoA/Rok is involved in substratum-mediated regulation
of insulin signaling in MECs, and it exerts an adverse effect in
cells that lack adherence to BM.
The Rho pathway and mammary differentiation
RhoGAP negatively regulates Rho activity. In p190-B
RhoGAP-deﬁcient mice, elevated RhoA activity results in
Rok-mediated IRS-1 serine phosphorylation and the
interruption of IGF-I signaling, thereby reducing cell and organ
size as well as promoting adipogenesis rather than myogenesis
from mesenchymal stem cells (Sordella et al., 2002, 2003).
Defective embryonic mammary bud development and adult
ductal morphogenesis, caused by decreased cell proliferation,
have been observed in these mice, and these features are
phenocopied in IGF-IR and IRS-1/2 knockout mice
(Chakravarty et al., 2003; Heckman et al., 2007). However, in
the mammary glands of p190-B overexpressing mice, ductal
morphogenesis is impaired and hyperplastic lesions is induced,
suggesting that a ﬁne tuning of Rho activity is required for
proper mammary gland development (Vargo-Gogola et al.,
2006).
Collectively, these studies demonstrate the role of RhoGAP
in development and differentiation through a control on
IGF-I/insulin signaling. This is consistent with our and other
observations that RhoA/Rok inhibits IGF-I/insulin signaling
(Farah et al., 1998; Begum et al., 2002; Kanda et al., 2006; Lim
et al., 2007; Noguchi et al., 2007; Xu et al., 2007).
One function of insulin is to cooperate with other lactogenic
hormones, prolactin and hydrocortisone, to promote milk
synthesis. In further studies, we have examined the effect of
RhoA/Rok on prolactin signaling and the expression a milk
protein gene, b-casein. As is the case with insulin signaling, we
found that RhoA/Rok had an inhibitory effect on prolactin
signaling (manuscript in preparation). We therefore suggest
that, in the absence of proper cell–BM interactions, an
over-activated RhoA/Rok pathway suppresses both insulin and
prolactin signaling, culminating in a milk deﬁciency and reduced
differentiation.
IRS-1 associates with SHP-2
A further mechanism for regulating insulin signaling is through
PTPs (Lee and Streuli, 1999). Here we examined PTPs targeting
to IR and IRS-1, particularly thosewhose effectwas regulated by
ECM, initially with the aim of identifying PTPs that might
suppress insulin signaling in cells cultured on plastic. However,
we were unable to identify the association of speciﬁc PTPs with
IRS-1 under these conditions. This suggests that the low levels
of tyrosine phosphorylation on IRS-1 are caused via a different
mechanism, which is likely to be the elevated serine
phosphorylation caused by Rok.
Using an in-gel assay, we found that several PTPs were
associatedwith IR but the extent of associationwas comparable
in cells cultured on plastic and BM (Fig. 7A). This is in agreement
with our previous result that insulin stimulates tyrosine
phosphorylation of IR irrespective of substratum (Lee and
Streuli, 1999). On the other hand, coprecipitation of SHP-2 and
IRS-1 in response to insulin was more prominent in cells
cultured on BM (Fig. 7B,C). This might be as a result of elevated
IRS-1 tyrosine phosphorylation (Lee and Streuli, 1999).
Furthermore, we found that the effect of RhoA/Rok on
IRS-1/SHP-2 association was similar to that on IRS-1 tyrosine
phosphorylation (Fig. 8), indicating that SHP-2 is not involved in
RhoA/Rok-mediated inhibition of insulin signaling. Here we
suggest that SHP-2might have a positive role in insulin signaling.
This agrees with previous studies where IRS-1 tyrosine
phosphorylation and downstream signaling are attenuated in
transgenic mice expressing dominant negative SHP-2 (Maegawa
et al., 1999). The underlyingmechanism for the positive effect of
SHP-2 on signaling likely occurs through dephosphorylating
docking sites for negative regulators (Ali et al., 2003; Neel et al.,
2003). Although our data suggest that SHP-2 does not play a
role in matrix-mediated control of insulin signaling, the
possibility that other PTPs are involved cannot be excluded.
Summary
We have dissected some aspects of the mechanism by which
cell–ECM interactions control insulin signaling in mammary
gland. We ﬁnd that cell adhesion to different substrata
differentially activates the RhoA/Rok pathway, which then
controls signal propagation downstream of IR by a mechanism
involving serine phosphorylation of IRS-1. Thus, the ECM
exerts an intricate control on the ability of MECs to receive and
respond to insulin signals, so that adhesion to a permissive BM
promotes signaling while it is prevented on stromal matrix. It is
likely that the tension of cytoskeleton, organization of cell
interior, compartmentalization of signaling molecules, and even
programming of gene expression are altered by different
microenvironmental constraints on cells. Perhaps the
integration of all these effects confers the ultimate selectivity in
insulin signaling.
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